Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions

Philip G. Nijland, Remco J. Molenaar, Susanne M. A. van der Pol, Paul van der Valk, Cornelis J. F. van Noorden, Helga E. de Vries, Jack van Horssen

Research output: Contribution to journalArticleAcademicpeer-review

35 Citations (Scopus)


Introduction: Demyelinated axons in multiple sclerosis (MS) lesions have an increased energy demand in order to maintain conduction. However, oxidative stress-induced mitochondrial dysfunction likely alters glucose metabolism and consequently impairs neuronal function in MS. Imaging and pathological studies indicate that glucose metabolism is altered in MS, although the underlying mechanisms and its role in neurodegeneration remain elusive. We investigated expression patterns of key enzymes involved in glycolysis, tricarboxylic acid (TCA) cycle and lactate metabolism in well-characterized MS tissue to establish which regulators of glucose metabolism are involved in MS and to identify underlying mechanisms. Results: Expression levels of glycolytic enzymes were increased in active and inactive MS lesions, whereas expression levels of enzymes involved in the TCA cycle were upregulated in active MS lesions, but not in inactive MS lesions. We observed reduced expression and production capacity of mitochondrial a-ketoglutarate dehydrogenase (alpha KGDH) in demyelinated axons, which correlated with signs of axonal dysfunction. In inactive lesions, increased expression of lactate-producing enzymes was observed in astrocytes, whereas lactate-catabolising enzymes were mainly detected in axons. Our results demonstrate that the expression of various enzymes involved in glucose metabolism is increased in both astrocytes and axons in active MS lesions. In inactive MS lesions, we provide evidence that astrocytes undergo a glycolytic shift resulting in enhanced astrocyte-axon lactate shuttling, which may be pivotal for the survival of demyelinated axons. Conclusion: In conclusion, we show that key enzymes involved in energy metabolism are differentially expressed in active and inactive MS lesions. Our findings imply that, in addition to reduced oxidative phosphorylation activity, other bioenergetic pathways are affected as well, which may contribute to ongoing axonal degeneration in MS
Original languageEnglish
Article number79
Pages (from-to)79
JournalActa neuropathologica communications
Issue number1
Publication statusPublished - 4 Dec 2015


  • Adult
  • Aged
  • Aged, 80 and over
  • Brain/enzymology
  • Cell Line, Tumor
  • Female
  • Gene Expression Regulation/drug effects
  • Glial Fibrillary Acidic Protein/metabolism
  • Glucose/metabolism
  • Humans
  • Interferon-gamma/pharmacology
  • Ketoglutarate Dehydrogenase Complex/metabolism
  • L-Lactate Dehydrogenase/metabolism
  • Male
  • Middle Aged
  • Multiple Sclerosis/pathology
  • Neuroblastoma/pathology
  • Tumor Necrosis Factor-alpha/metabolism
  • tert-Butylhydroperoxide/pharmacology

Cite this